Randomized phase II trial of IGRT with or without HDR boost in intermediate-risk prostate cancer

被引：1
|
作者：
Vigneault, E. [1 ]
Morton, G. [2 ]
Perulekar, W. [3 ]
Niazi, T. [4 ]
Springer, G. [5 ]
Barkati, M. [6 ]
Chung, P. [7 ]
Koll, W. [8 ]
Kamran, A. [9 ]
Montreal, M. [3 ]
Ding, K. [3 ]
Loblaw, A. [2 ]
机构：
[1] CHU Quebec, Hotel Dieu Quebec, Radiat Oncol & Res Ctr, Quebec City, PQ, Canada
[2] Odette Canc Ctr, Radiat Oncol, Toronto, ON, Canada
[3] Queens Univ, Canadian Canc Trials Grp, Kingston, ON, Canada
[4] Mc Gill Jewish Gen Hosp, Dept Radiat Oncol, Montreal, PQ, Canada
[5] Windsor Reg Hosp, Radiat Oncol, Windsor, ON, Canada
[6] CHUM Hop Notre Dame, Radiat Oncol, Montreal, PQ, Canada
[7] Univ Hlth Network, Princess Margaret Canc Ctr, Radiat Oncol, Toronto, ON, Canada
[8] Lakeridge Hosp, Radiat Oncol, Oshawa, ON, Canada
[9] Dr H Bliss Murphy Canc Ctr, Radiat Oncol, St John, NF, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2017年 / 123卷
关键词：
D O I：
10.1016/S0167-8140(17)32136-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1774
引用
收藏
页码：S975 / S976
页数：2
相关论文
共 50 条
  • [21] Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial
    Nabid, Abdenour
    Carrier, Nathalie
    Vigneault, Eric
    Thu Van Nguyen
    Vavassis, Peter
    Brassard, Marc-Andre
    Bahoric, Boris
    Archambault, Robert
    Vincent, Francois
    Bettahar, Redouane
    Wilke, Derek
    Souhami, Luis
    EUROPEAN JOURNAL OF CANCER, 2021, 143 : 64 - 74
  • [22] Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients
    Martell, K.
    Mendez, L. C.
    Chung, H. T.
    Tseng, C. L.
    Alayed, Y.
    Cheung, P.
    Liu, S.
    Vesprini, D.
    Chu, W.
    Wronski, M.
    Szumacher, E.
    Ravi, A.
    Loblaw, A.
    Morton, G.
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : 149 - 155
  • [23] Patient-Reported Quality of Life in Low and Intermediate Risk Prostate Cancer Patients Randomized a Phase II Randomized Trial of HDR Brachytherapy As Monotherapy (BRP2)
    Jolicoeur, M.
    Nguyen-Huynh, T. V.
    Derashodian, T.
    Hellmann, E. de Castro
    Wakil, G.
    Nachabe, M.
    Antebi, E.
    Heliou, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S98 - S98
  • [24] MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial
    Ghai, Sangeet
    Finelli, Antonio
    Corr, Kateri
    Chan, Rosanna
    Jokhu, Sarah
    Li, Xuan
    McCluskey, Stuart
    Konukhova, Anna
    Hlasny, Eugen
    van der Kwast, Theodorus H.
    Incze, Peter F.
    Zlotta, Alexandre R.
    Hamilton, Robert J.
    Haider, Masoom A.
    Kucharczyk, Walter
    Perlis, Nathan
    RADIOLOGY, 2021, 298 (03) : 695 - 703
  • [25] Radiation Therapy With or Without Short-Term Androgen Deprivation Therapy in Intermediate-Risk Prostate Cancer: Results of a Phase 3 Trial
    Nabid, A.
    Carrier, N.
    Vigneault, E.
    Souhami, L.
    Lemaire, C.
    Brassard, M. A.
    Bahoric, B.
    Archambault, R.
    Vincent, F.
    Nguyen, T. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (01): : 4 - 4
  • [26] Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer
    Freytag, Svend O.
    Stricker, Hans
    Lu, Mei
    Elshaikh, Mohamed
    Aref, Ibrahim
    Pradhan, Deepak
    Levin, Kenneth
    Kim, Jae Ho
    Peabody, James
    Siddiqui, Farzan
    Barton, Kenneth
    Pegg, Jan
    Zhang, Yingshu
    Cheng, Jingfang
    Oja-Tebbe, Nancy
    Bourgeois, Renee
    Gupta, Nilesh
    Lane, Zhaoli
    Rodriguez, Ron
    DeWeese, Theodore
    Movsas, Benjamin
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (02): : 268 - 276
  • [27] Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
    Spratt, Daniel E.
    Liu, Vinnie Y. T.
    Michalski, Jeff
    Davicioni, Elai
    Berlin, Alejandro
    Simko, Jeffry P.
    Efstathiou, Jason A.
    Tran, Phuoc T.
    Sandler, Howard M.
    Hall, William A.
    Thompson, Darby J. S.
    Parliament, Matthew B.
    Dayes, Ian S.
    Correa, Rohann Jonathan Mark
    Robertson, John M.
    Gore, Elizabeth M.
    Doncals, Desiree E.
    Vigneault, Eric
    Souhami, Luis
    Karrison, Theodore G.
    Feng, Felix Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : 370 - 377
  • [28] Active surveillance in intermediate-risk prostate cancer
    Klotz, Laurence
    BJU INTERNATIONAL, 2020, 125 (03) : 346 - 354
  • [29] Active surveillance for intermediate-risk prostate cancer
    M A Dall'Era
    L Klotz
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 1 - 6
  • [30] Active surveillance for intermediate-risk prostate cancer
    Dall'Era, M. A.
    Klotz, L.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (01) : 1 - 6
12345